![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RE Kuestner, RD Elrod, FJ Grant, FS Hagen, JL Kuijper, SL Matthewes, PJ O'Hara, PO Sheppard, SD Stroop and DL Thompson
ZymoGenetics Inc., Seattle, Washington 98102.
We have cloned and characterized a second form of the human calcitonin receptor from T47D cells. It resembles the clone described by Gorn et al. [J. Clin. Invest. 90:1726-1735 (1992)] except that it lacks a 16- amino acid insert in the putative first intracellular loop. The insert- negative receptor appears to be the most abundant form, and it occurs at a relatively constant level in all expressing tissues. In contrast, the insert-positive receptor is found at low levels in most tissues but its expression levels appear to be much more variable. The insert- negative cDNA was stably expressed in baby hamster kidney cells. Like the endogenous T47D receptor, the recombinant receptor has an equally high affinity for salmon and porcine calcitonin but a 3-4-fold lower affinity for human calcitonin. High concentrations of calcitonin gene- related peptide, rat amylin, secretin, or vasoactive intestinal peptide do not significantly compete with calcitonin for binding to the recombinant receptor. Calcitonin stimulates a cAMP response in both T47D and transfected baby hamster kidney cells. Salmon calcitonin is more potent than human calcitonin for T47D cells, but the two are nearly equipotent for the transfectants. Furthermore, the ED50 for the cAMP response in the transfectants is 10-100-fold lower than in T47D cells. Calcitonin stimulates inositol phosphate turnover and elevates internal calcium levels in the transfectants. This response requires non-physiological levels of calcitonin and is directly correlated with the number of receptors. Lastly, by using a human/rodent somatic cell hybrid panel and in situ hybridization, we localized the human calcitonin receptor gene to chromosome 7.
This article has been cited by other articles:
|
|
 |
|
  D. L. Hay, G. Christopoulos, A. Christopoulos, and P. M. Sexton Mol. Pharmacol., December 1, 2006; 70(6): 1984 - 1991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Udawela, G. Christopoulos, M. Morfis, A. Christopoulos, S. Ye, N. Tilakaratne, and P. M. Sexton A Critical Role for the Short Intracellular C Terminus in Receptor Activity-Modifying Protein Function Mol. Pharmacol., November 1, 2006; 70(5): 1750 - 1760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Hay, G. Christopoulos, A. Christopoulos, D. R. Poyner, and P. M. Sexton Pharmacological Discrimination of Calcitonin Receptor: Receptor Activity-Modifying Protein Complexes Mol. Pharmacol., May 1, 2005; 67(5): 1655 - 1665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Pham, J. D. Wade, B. W. Purdue, and P. M. Sexton Spatial Proximity between a Photolabile Residue in Position 19 of Salmon Calcitonin and the Amino Terminus of the Human Calcitonin Receptor J. Biol. Chem., February 20, 2004; 279(8): 6720 - 6729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kuwasako, Y.-N. Cao, Y. Nagoshi, T. Tsuruda, K. Kitamura, and T. Eto Characterization of the Human Calcitonin Gene-Related Peptide Receptor Subtypes Associated with Receptor Activity-Modifying Proteins Mol. Pharmacol., January 1, 2004; 65(1): 207 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yaoi, M. Suzuki, H. Tomura, Y. Sasayama, S. Kikuyama, and S. Tanaka Molecular Cloning of Otoconin-22 Complementary Deoxyribonucleic Acid in the Bullfrog Endolymphatic Sac: Effect of Calcitonin on Otoconin-22 Messenger Ribonucleic Acid Levels Endocrinology, August 1, 2003; 144(8): 3287 - 3296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Li, J. Wang, D. R. Armant, M. K. Bagchi, and I. C. Bagchi Calcitonin Down-regulates E-cadherin Expression in Rodent Uterine Epithelium during Implantation J. Biol. Chem., November 22, 2002; 277(48): 46447 - 46455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Poyner, P. M. Sexton, I. Marshall, D. M. Smith, R. Quirion, W. Born, R. Muff, J. A. Fischer, and S. M. Foord International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors Pharmacol. Rev., June 1, 2002; 54(2): 233 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Santhanagopal, P. Chidiac, W. C. Horne, R. Baron, and S. J. Dixon Calcitonin (CT) Rapidly Increases Na+/H+ Exchange and Metabolic Acid Production: Effects Mediated Selectively by the C1a CT Receptor Isoform Endocrinology, October 1, 2001; 142(10): 4401 - 4413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Tverberg, M. F. Gustafson, T. L. Scott, I. V. Arzumanova, E. R. Provost, A. W. Yan, and S. A. Rawie Induction of Calcitonin and Calcitonin Receptor Expression in Rat Mammary Tissue during Pregnancy Endocrinology, October 1, 2000; 141(10): 3696 - 3702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Samura, S. Wada, S. Suda, M. Iitaka, and S. Katayama Calcitonin Receptor Regulation and Responsiveness to Calcitonin in Human Osteoclast-Like Cells Prepared in Vitro using Receptor Activator of Nuclear Factor-{kappa}B Ligand and Macrophage Colony-Stimulating Factor Endocrinology, October 1, 2000; 141(10): 3774 - 3782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tilakaratne, G. Christopoulos, E. T. Zumpe, S. M. Foord, and P. M. Sexton Amylin Receptor Phenotypes Derived from Human Calcitonin Receptor/RAMP Coexpression Exhibit Pharmacological Differences Dependent on Receptor Isoform and Host Cell Environment J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 61 - 72. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Evdokiou, L.-J. Raggatt, G. J. Atkins, and D. M. Findlay Calcitonin Receptor-Mediated Growth Suppression of HEK-293 Cells Is Accompanied by Induction of p21WAF1/CIP1 and G2/M Arrest Mol. Endocrinol., October 1, 1999; 13(10): 1738 - 1750. [Abstract] [Full Text]
|
|
|
|
|
|
S. R. J. Hoare, T. I. Bonner, and T. B. Usdin Comparison of Rat and Human Parathyroid Hormone 2 (PTH2) Receptor Activation: PTH Is a Low Potency Partial Agonist at the Rat PTH2 Receptor Endocrinology, October 1, 1999; 140(10): 4419 - 4425. [Abstract] [Full Text]
|
|
|
|
|
|
G. Christopoulos, K. J. Perry, M. Morfis, N. Tilakaratne, Y. Gao, N. J. Fraser, M. J. Main, S. M. Foord, and P. M. Sexton Multiple Amylin Receptors Arise from Receptor Activity-Modifying Protein Interaction with the Calcitonin Receptor Gene Product Mol. Pharmacol., July 1, 1999; 56(1): 235 - 242. [Abstract] [Full Text]
|
|
|
|
|
|
D. Inoue, C. Shih, D. L. Galson, S. R. Goldring, W. C. Horne, and R. Baron Calcitonin-Dependent Down-Regulation of the Mouse C1a Calcitonin Receptor in Cells of the Osteoclast Lineage Involves a Transcriptional Mechanism Endocrinology, March 1, 1999; 140(3): 1060 - 1068. [Abstract] [Full Text]
|
|
|
|
|
|
F. Naro, M. Perez, S. Migliaccio, D. L. Galson, P. Orcel, A. Teti, and S. R. Goldring Phospholipase D- and Protein Kinase C Isoenzyme-Dependent Signal Transduction Pathways Activated by the Calcitonin Receptor Endocrinology, July 1, 1998; 139(7): 3241 - 3248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-f. Xu, H. Andersen, T. E. Whitmore, S. R. Presnell, D. P. Yee, A. Ching, T. Gilbert, E. W. Davie, and D. C. Foster Cloning and characterization of human protease-activated receptor 4 PNAS, June 9, 1998; 95(12): 6642 - 6646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Chai, G. Christopoulos, M. E. Cooper, and P. M. Sexton Characterization of binding sites for amylin, calcitonin, and CGRP in primate kidney Am J Physiol Renal Physiol, January 1, 1998; 274(1): F51 - F62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-J. Chen, S. Armour, J. Way, G. Chen, C. Watson, P. Irving, J. Cobb, S. Kadwell, K. Beaumont, T. Rimele, et al. Expression Cloning and Receptor Pharmacology of Human Calcitonin Receptors from MCF-7 Cells and Their Relationship to Amylin Receptors Mol. Pharmacol., December 1, 1997; 52(6): 1164 - 1175. [Abstract] [Full Text]
|
|
|
|
|
|
K. J. Perry, M. Quiza, D. E. Myers, M. Morfis, G. Christopoulos, and P. M. Sexton Characterization of Amylin and Calcitonin Receptor Binding in the Mouse {alpha}-Thyroid-Stimulating Hormone Thyrotroph Cell Line Endocrinology, August 1, 1997; 138(8): 3486 - 3496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Quiza, M. Dowton, K. J. Perry, and P. M. Sexton Electrophoretic Mobility and Glycosylation Characteristics of Heterogeneously Expressed Calcitonin Receptors Endocrinology, February 1, 1997; 138(2): 530 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Shyu, D. Inoue, R. Baron, and W. C. Horne The Deletion of 14Amino Acids in the Seventh Transmembrane Domain of a Naturally Occurring Calcitonin Receptor Isoform Alters Ligand Binding and Selectively Abolishes Coupling to Phospholipase C J. Biol. Chem., December 6, 1996; 271(49): 31127 - 31134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Anusaksathien, C. Laplace, X. Li, Y. Ren, L. Peng, S. R. Goldring, and D. L. Galson Tissue-specific and Ubiquitous Promoters Direct the Expression of Alternatively Spliced Transcripts from the Calcitonin Receptor Gene J. Biol. Chem., June 15, 2001; 276(25): 22663 - 22674. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
